RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Revenue growth (%)

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Dec 31, 202411.3-53.70%
Dec 31, 202324.5+29.99%
Dec 31, 202218.8-30.43%
Dec 31, 202127.1-11.33%
Dec 31, 202030.5-29.11%
Dec 31, 201943.1-1.15%
Dec 31, 201843.6+72.05%
Dec 31, 201725.3-40.55%
Dec 31, 201642.6-22.65%
Dec 31, 201555.1-11.15%
Dec 31, 201462+3.06%
Dec 31, 201360.2+94.13%
Dec 31, 201231

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)